Walleye Trading
VKTX icon

Walleye Trading’s Viking Therapeutics VKTX Stock Holding History

Walleye Trading’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.71M Sell
144,600
-47,900
-25% -$1.54M 0.01% 1178
2025
Q4 		$6.77M Sell
192,500
-300
-0.2% -$10.6K 0.01% 1125
2025
Q3 		$5.07M Buy
192,800
+50,100
+35% +$1.49M 0.01% 1247
2025
Q2 		$3.78M Buy
142,700
+102,500
+255% +$2.7M 0.01% 1361
2025
Q1 		$971K Buy
40,200
+8,900
+28% +$281K ﹤0.01% 2075
2024
Q4 		$1.26M Buy
31,300
+7,300
+30% +$416K ﹤0.01% 2000
2024
Q3 		$1.52M Buy
24,000
+22,000
+1,100% +$1.29M ﹤0.01% 1852
2024
Q2 		$106K Sell
2,000
-2,000
-50% -$131K ﹤0.01% 3355
2024
Q1 		$328K Sell
4,000
-21,400
-84% -$952K ﹤0.01% 3122
2023
Q4 		$473K Buy
25,400
+18,500
+268% +$242K ﹤0.01% 3122
2023
Q3 		$76.4K Buy
6,900
+1,000
+17% +$14.3K ﹤0.01% 4080
2023
Q2 		$95.6K Buy
5,900
+1,800
+44% +$37.7K ﹤0.01% 3764
2023
Q1 		$68.3K Sell
4,100
-8,100
-66% -$83.7K ﹤0.01% 3985
2022
Q4 		$115K Buy
+12,200
New +$54.5K ﹤0.01% 3903
2020
Q1 		– Sell
-1,900
Closed -$15K – 4626
2019
Q4 		$15K Buy
+1,900
New +$13.9K ﹤0.01% 4028
2019
Q3 		– Sell
-500
Closed -$4K – 4471
2019
Q2 		$4K Sell
500
-200
-29% -$1.71K ﹤0.01% 3912
2019
Q1 		$7K Sell
700
-24,200
-97% -$203K ﹤0.01% 4025
2018
Q4 		$190K Buy
+24,900
New +$298K ﹤0.01% 3436

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Walleye Trading's VKTX Position: Q1 2026 in Review

Walleye Trading reduced its Viking Therapeutics (VKTX) stake by 95% in Q1 2026, selling an estimated $6.49M and leaving 10,007 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #2837.

Walleye Trading first reported a position in VKTX in Q1 2018 and has held it in 18 quarters since. The position peaked at $7.45M in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Walleye Trading held 10,007 shares of Viking Therapeutics worth $326K as of Q1 2026.
  • Walleye Trading sold 201,897 Viking Therapeutics shares in Q1 2026, an estimated $6.49M.
  • Viking Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2837 holding.
  • Walleye Trading first reported a position in Viking Therapeutics in Q1 2018 and has held it in 18 quarters since.
  • Walleye Trading's Viking Therapeutics position peaked at $7.45M in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.